Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

Mumbai: The Vegetarian Society will hold its bi-monthly talk on Thursday, February 13, at Samrat Restaurant, Churchgate ...

Ahead of this weekend's Super Bowl, some good news for the athletes: NFL players are largely avoiding opioid-based pain ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

Scientists reveal how CBD could help ease chronic pain, anxiety, and mood disorders. Researchers have uncovered a potential ...

12 Simple Decor Choices That Instantly Make Your Home Look More Expensive Near-Earth asteroid Bennu could hit Earth in 157 ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...